TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

HUONS

OphthalmologyCardiovascularImmunology
Generics

HUONS is a generic drug manufacturer focused on Ophthalmology, Cardiovascular, Immunology.

2019
Since
2
Drugs
-
Trials
11
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

LIDOCAINE HYDROCHLORIDE 2025-10-02
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-09-26
Labeling
LIDOCAINE HYDROCHLORIDE 2025-08-27
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
LIDOCAINE HYDROCHLORIDE 2025-07-29
LIDOCAINE HYDROCHLORIDE 2025-04-02
BUPIVACAINE HYDROCHLORIDE 2025-02-28
Labeling
BUPIVACAINE HYDROCHLORIDE 2024-10-25
Labeling
LIDOCAINE HYDROCHLORIDE 2024-04-29
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Ophthalmology 65%
0 drugs Phase 3: 5 Phase 2: 1
Cardiovascular 15%
0 drugs Phase 3: 1 Phase 1: 1
Immunology 12%
0 drugs Phase 3: 1
Metabolic 9%
0 drugs Phase 1: 3

Pipeline Strength Pro

Loading...

Competitors Pro

Novartis big-pharma
Cardiovascular, Immunology, Ophthalmology
Merck big-pharma
Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Immunology, Cardiovascular, Metabolic
UPJOHN big-pharma
Cardiovascular, Metabolic, Immunology, Ophthalmology
Bayer big-pharma
Cardiovascular, Ophthalmology, Metabolic